Longitudinal assessment of growth and bone mineral accretion in prematurely born infants treated for chronic lung disease with dexamethasone
- 20 February 1997
- journal article
- clinical trial
- Published by Elsevier in Early Human Development
- Vol. 47 (3) , 271-286
- https://doi.org/10.1016/s0378-3782(96)01783-5
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Pulse dexamethasone does not impair growth and body composition of very low birth weight infants.Journal of the American College of Nutrition, 1995
- Effect of pulse dexamethasone therapy on the incidence and severity of chronic lung disease in the very low birth weight infantThe Journal of Pediatrics, 1995
- Twenty-month outcome in ventilator-dependent, very low birth weight infants born during the early years of dexamethasone therapyThe Journal of Pediatrics, 1995
- Effect of dexamethasone on protein metabolism in infants with bronchopulmonary dysplasiaThe Journal of Pediatrics, 1994
- Catch-U Head Growth and Motor Performance in Very-Low-Birthweight InfantsClinical Pediatrics, 1993
- The effectiveness and side effects of dexamethasone in preterm infants with bronchopulmonary dysplasia.Archives of Disease in Childhood, 1993
- Effect of dexamethasone on proliferating osteoblasts: Inhibition of prostaglandin E2 synthesis, DNA synthesis, and alterations in actin cytoskeletonExperimental Cell Research, 1992
- Dexamethasone increases plasma amino acid concentrations in bronchopulmonary dysplasia.Archives of Disease in Childhood, 1992
- A Controlled Trial of Dexamethasone in Preterm Infants at High Risk for Bronchopulmonary DysplasiaNew England Journal of Medicine, 1989
- Human milk feeding in premature infants: Protein,fat, and carbohydrate balances in the first two weeks of lifeThe Journal of Pediatrics, 1981